A

Amgen

Makes biotech medicines for serious illnesses

Director – Global Regulatory Affairs - Cardiometabolic Disorders

Regulatory & Quality (Life Sciences)Updated on Nov 5
Full-timeRemote in USARemote

About the Job

Requirements

  • A doctorate degree and 4 years of regulatory experience, or a master’s degree and 7 years of regulatory experience, or a bachelor’s degree and 9 years of regulatory experience.
  • Strong scientific literacy in metabolism, energy balance physiology, hormone signaling pathways, adiposity biology, and associated clinical endpoints.
  • Experience developing global submissions and leading interactions with the FDA, EMA, and other regulatory bodies.
  • Demonstrated success leading Global Regulatory Teams and influencing governance bodies on complex regulatory and clinical development issues.
  • Ability to translate metabolic science into clear regulatory strategy and decision-making frameworks.
  • Strong communication and negotiation skills, with the ability to guide teams through ambiguous or high-stakes situations.

Responsibilities

  • Develop and lead global regulatory strategy for obesity and metabolic disease programs, grounded in understanding of metabolic biology, endocrine pathways, adiposity-related physiology, and cardiometabolic risk science.
  • Integrate clinical, nonclinical, chemistry, manufacturing, and controls, and safety evidence into cohesive regulatory recommendations, accounting for regulatory precedent in obesity and related conditions.
  • Lead creation of the Global Regulatory Strategic Plan, including risk assessment, regulatory scenario planning, and evaluation of novel or expedited pathways.
  • Advise on clinical development elements relevant to obesity programs, including study designs, chronic treatment safety, cardiovascular outcomes evaluation, metabolic biomarker selection, pediatric development, and real-world evidence plans.
  • Lead the Global Regulatory Team and represent Global Regulatory Affairs and Strategy on cross-functional teams, including Indication, Evidence Generation, and Global Safety Teams.
  • Partner with Clinical Development, Safety, Chemistry, Manufacturing, and Controls, Value and Access, Commercial, and regional regulatory colleagues to ensure strategy execution.
  • Translate complex metabolic science into actionable regulatory strategy for cross-functional partners, facilitating alignment on risk–benefit thinking and long-term labeling strategy.
  • Oversee execution of major global regulatory submissions, including clinical trial applications, initial and supplemental marketing applications, pediatric plans, and labeling updates relevant to obesity programs.
  • Ensure consistency, scientific rigor, and clarity across core regulatory documents, especially TPL, CDS, and briefing materials.
  • Guide regulatory interpretation of evolving FDA and EMA guidance related to obesity and related conditions, where applicable.
  • Lead strategy development, preparation, and cross-functional alignment for Health Authority interactions with the FDA, EMA, PMDA, NMPA, and other authorities on obesity and other cardiometabolic indications, including protocol advice, cardiovascular safety considerations, efficacy endpoints, long-term safety monitoring, and pediatric and labeling discussions.
  • Represent Amgen in external alliances, consortia, scientific policy discussions, and trade associations focused on obesity, metabolic disease, or cardiometabolic health.
  • Anticipate Health Authority perspectives based on precedent in obesity, including benefit–risk expectations, cardiovascular outcomes requirements, and weight-loss durability concerns, and prepare teams for high-stakes discussions.
  • Build, mentor, and support high-performing global regulatory teams.
  • Foster an inclusive, collaborative environment that encourages diverse perspectives, scientific rigor, and healthy debate.
  • Develop regulatory talent with expertise in metabolic disease science, regulatory strategy, and global execution.

Desired Qualifications

  • 8–10 or more years of global regulatory experience, with demonstrated leadership of regulatory strategy for programs in obesity, metabolic disorders, endocrinology, cardiovascular risk, or related therapeutic areas.
  • Experience in real-world evidence strategy, long-term outcome measures, and chronic disease regulatory considerations.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs